Aggressive mature natural killer cell neoplasms: report on a series of 12 European patients with emphasis on flow cytometry based immunophenotype and DNA content of neoplastic natural killer cells

References

• Semenzato G, Marino F, Zambello R. State of the art in natural killer cell malignancies. Int J Lab Hematol 2012;34:117–128.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008.
   Google Scholar
• Chan JKC, Quintanilla-Martinez L, Ferry JA, et al. Extranodal NK/T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. pp. 285–288.
   Google Scholar
• Chan JKC, Jane ES, Ralfkiaer E, et al. Aggressive NK-cell leukaemia. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. pp 276–267.
   Google Scholar
• Borowitz MJ, Bene ME, Harris NL, et al. Acute leukaemias of ambiguous lineage. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. pp 150–155.
   Google Scholar
• Villamor N, Morice WG, Chan WC, et al. Chronic lymphoproliferative disorders of NK cells. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. pp. 274–275.
   Google Scholar
• Yook-Lam K. The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia. J Clin Exp Hematop J 2011;51:21–28.
   PubMedGoogle Scholar
• Kanavaros P, Lescs MC, Brière J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993;81:2688–2695.
   PubMed Web of Science ®Google Scholar
• Oshimi K, Kawa K, Nakamura S, et al. NK-cell neoplasms in Japan. Hematology 2005;10:237–245.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Suzumiya J, Yamaguchi M, et al.; NK-cell Tumor Study Group. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol 2010;21:1032–1040.
   PubMed Web of Science ®Google Scholar
• Au W-Y, Weisenburger D, Intragumtornchai T, et al.; International Peripheral T-Cell Lymphoma Project. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009;113:3931–3937.
   PubMed Web of Science ®Google Scholar
• Pagano L, Gallamini A, Trapè G, et al.; Intergruppo Italiano Linfomi. NK/T-cell lymphomas “nasal type”: an Italian multicentric retrospective survey. Ann Oncol 2006;17:794–800.
   PubMed Web of Science ®Google Scholar
• Murdock J, Jaffe ES, Wilson WH, et al. Aggressive natural killer cell leukemia/lymphoma: case report, use of telesynergy and review of the literature. Leuk Lymphoma 2004;45:1269–1273.
   PubMed Web of Science ®Google Scholar
• Guerrero AM, Lira VP, Bertin CP, et al.[Natural killer cell leukemia. Case report]. Rev Médica Chile 2005;133:457–460.
   PubMed Web of Science ®Google Scholar
• Castelli R, Molteni M, Gianelli U, et al. Aggressive natural killer cell leukaemia with a complex karyotype: a case report. Ann Hematol 2006;85:66–68.
   PubMed Web of Science ®Google Scholar
• Sousa J, Cabezuelo L, Almeida S, et al. [Aggressive NK/ T cell leukemia/lymphoma associated with EBV]. Acta Médica Port 2011;24(Suppl. 3);649–652.
   Google Scholar
• Cheung MMC, Chan JKC, Wong K-F. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias. Semin Hematol 2003;40:221–232.
   PubMed Web of Science ®Google Scholar
• Gualco G, Domeny-Duarte P, Chioato L, et al. Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis. Am J Surg Pathol 2011;35:1195–1203.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Suzumiya J, Oshimi K. Differences between nasal and extranasal NK/T-cell lymphoma. Blood 2009;113:6260–6261; author reply 6261–6262.
   PubMed Web of Science ®Google Scholar
• Gill H, Liang RHS, Tse E. Extranodal natural-killer/T-cell lymphoma, nasal type. Adv Hematol 2010;2010:627401.
   PubMedGoogle Scholar
• Wong KF, Chan JK, Cheung MM, et al. Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon. Am J Clin Pathol 2001;115:266–270.
   PubMed Web of Science ®Google Scholar
• Ruskova A, Abizanda R, Chan G. Aggressive natural killer-cell leukemia: report of five cases and review of the literature. Leuk Lymphoma 2004;45:2427–2438.
   PubMed Web of Science ®Google Scholar
• Ryder J, Wang X, Bao L, et al. Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature. Int J Hematol 2007;85:18–25.
   PubMed Web of Science ®Google Scholar
• Tse E, Kwong Y-L. Treatment algorithms for mature T-cell and natural killer-cell neoplasms. Future Oncol 2011;7:1101–1112.
   PubMed Web of Science ®Google Scholar
• Liang X, Graham DK. Natural killer cell neoplasms. Cancer 2008;112:1425–1436.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Matthiesen P, Harder S, et al. A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer 2000;27:52–58.
   PubMed Web of Science ®Google Scholar
• Sun HS, Su I-J, Lin Y-C, et al. A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/ T-cell lymphoma. Br J Haematol 2003;122:590–599.
   PubMed Web of Science ®Google Scholar
• Nakashima Y, Tagawa H, Suzuki R, et al. Genome-wide array- based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma, nasal type. Genes Chromosomes Cancer 2005;44:247–255.
   PubMed Web of Science ®Google Scholar
• Gaal K, Sun NC, Hernandez AM, et al. Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol 2000;24:1511–1517.
   PubMed Web of Science ®Google Scholar
• Schwartz EJ, Molina-Kirsch H, Zhao S, et al. Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases. Am J Clin Pathol 2008;130:343–351.
   PubMed Web of Science ®Google Scholar
• Haedicke W, Ho FC, Chott A, et al. Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. Blood 2000;95:3628–3630.
   PubMed Web of Science ®Google Scholar
• Mori KL, Egashira M, Oshimi K. Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis. Br J Haematol 2001;115:225–228.
   PubMed Web of Science ®Google Scholar
• Dukers DF, Vermeer MH, Jaspars LH, et al. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype. J Clin Pathol 2001;54:224–228.
   PubMed Web of Science ®Google Scholar
• Sawada A, Sato E, Koyama M, et al. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect. Am J Hematol 2006;81:576–581.
   PubMed Web of Science ®Google Scholar
• Falcão RP, Rizzatti EG, Saggioro FP, et al. Flow cytometry characterization of leukemic phase of nasal NK/T-cell lymphoma in tumor biopsies and peripheral blood. Haematologica 2007;92:e24–e25.
   PubMed Web of Science ®Google Scholar
• Nong L, Zhang S, Li Y, et al. [Study on expression of natural killer (NK) cell C-type lectin-like receptors in nasal NK/T-cell lymphomas]. Zhonghua Bing Li Xue Za Zhi 2010;39:319–324.
   PubMedGoogle Scholar
• Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, et al. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol 1998;11:754–761.
   PubMed Web of Science ®Google Scholar
• Jiang N-G, Jin Y-M, Niu Q, et al. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood. Ann Hematol 2013;92:89–96.
   PubMed Web of Science ®Google Scholar
• Lima M, Gonçalves C, Teixeira MA, et al. Aggressive natural- killer cell lymphoma presenting with skin lesions, breast nodule, suprarenal masses and life-threatening pericardial and pleural effusions. Leuk Lymphoma 2001;42:1385–1391.
   PubMed Web of Science ®Google Scholar
• Lima M, Teixeira MA, Queirós ML, et al. Immunophenotypic characterization of normal blood CD56 + lo versus CD56 + hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties. Blood Cells Mol Dis 2001;27:731–743.
   PubMed Web of Science ®Google Scholar
• Lima M, Almeida J, Montero AG, et al. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+ dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 2004;165:1117–1127.
   PubMed Web of Science ®Google Scholar
• Lima M, Teixeira Mdos A, Fonseca S, et al. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies. Blood Cells Mol Dis 2000;26:634–645.
   PubMedGoogle Scholar
• van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations:report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257–2317.
   PubMed Web of Science ®Google Scholar
• Ogata M, Imamura T, Mizunoe S, et al. Natural killer cell- type body cavity lymphoma following chronic active Epstein-Barr virus infection. Am J Hematol 2003;73:126–130.
   PubMed Web of Science ®Google Scholar
• Pullarkat VA, Medeiros LJ, Brynes RK. Body cavity-based presentation of natural killer cell lymphoma. Leuk Lymphoma 2005;46:293–296.
   PubMed Web of Science ®Google Scholar
• Lepeak LM, Yang DT, Chang JE. Extranodal NK/T-cell lymphoma presenting with primary cardiac involvement. Hematol Rep 2011; 31:e9.
   Google Scholar
• Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001;22:633–640.
   PubMed Web of Science ®Google Scholar
• Poli A, Michel T, Thérésine M, et al. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009;126:458–465.
   PubMed Web of Science ®Google Scholar
• Moretta L, Moretta A. Killer immunoglobulin-like receptors. Curr Opin Immunol 2004;16:626–633.
   PubMed Web of Science ®Google Scholar
• Lima M, Almeida J, dos Anjos Teixeira M, et al. The “ex vivo” patterns of CD2/CD7, CD57/CD11c, CD38/CD11b, CD45RA/CD45RO, and CD11a/HLA-DR expression identify acute/early and chronic/ late NK-cell activation states. Blood Cell Mol Dis 2002;28:181–190.
   PubMed Web of Science ®Google Scholar
• Lima M, Almeida J, Teixeira MA, et al. Reactive phenotypes after acute and chronic NK-cell activation. J Biol Regul Homeost Agents 2004;18:331–334.
   PubMed Web of Science ®Google Scholar
• Galea-Lauri J, Darling D, Gan SU, et al. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. J Immunol 1999;163:62–70.
   PubMed Web of Science ®Google Scholar
• Wilson JL, Charo J, Martín-Fontecha A, et al. NK cell triggering by the human costimulatory molecules CD80 and CD86. J Immunol 1999;163:4207–4212.
   PubMed Web of Science ®Google Scholar
• Geldhof AB, Moser M, Lespagnard L, et al. Interleukin- 12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells. Blood 1998;91:196–206.
   PubMed Web of Science ®Google Scholar
• Walker W, Aste-Amezaga M, Kastelein RA, et al. IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma. J Immunol 1999;162:5894–5901.
   PubMed Web of Science ®Google Scholar
• Azuma M, Cayabyab M, Buck D, et al. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J Immunol 1992;149:1115–1123.
   PubMed Web of Science ®Google Scholar
• Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994;8:652–658.
   PubMed Web of Science ®Google Scholar
• Chen X, Allan DSJ, Krzewski K, et al. CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells. Proc Natl Acad Sci USA 2006;103:10346–10351.
   PubMed Web of Science ®Google Scholar
• Bühling F, Kunz D, Reinhold D, et al. Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells. Nat Immun 1994;13:270–279.
   PubMedGoogle Scholar
• Robertson MJ, Cochran KJ, Cameron C, et al. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 1996;24:406–415.
   PubMed Web of Science ®Google Scholar
• Thompson MA, Ohnuma K, Abe M, et al. CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders. Mini Rev Med Chem 2007;7:253–273.
   PubMed Web of Science ®Google Scholar
• Montaldo E, Del Zotto G, Della Chiesa M, et al. Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function. Cytometry A 2013;83:702–713.
   PubMed Web of Science ®Google Scholar